Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years) at Risk for SARS-CoV-2

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04611802
Recruitment Status : Active, not recruiting
First Posted : November 2, 2020
Last Update Posted : January 11, 2022
Department of Health and Human Services
Information provided by (Responsible Party):